DR. MARK FRANKLIN PEAKE M.D. NPI 1336244581

NPI Details

DR. Mark Franklin Peake, M.D. is a pediatric dermatology dermatology in El Paso, TX with 38 years of experience. The provider is a pediatric dermatologist has, through additional special training, developed expertise in the treatment of specific skin disease categories with emphasis on those diseases which predominate in infants, children and adolescents. DR. Mark Franklin Peake, M.D. NPI is 1336244581. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF TEXAS MEDICAL SCHOOL AT SAN ANTONIO
Graduation Year:1988

The provider's business location address is:

8820 GATEWAY BLVD N
EL PASO, TX
ZIP 79904-947
Phone: (915) 759-7700
Fax: (915) 759-7778

The NPI 1336244581 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Destruction of precancer skin growth, 2-14 growths (HCPCS:17003)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Destruction of precancer skin growth, 1 growth (HCPCS:17000)
• Therapy procedure using ultraviolet radiation with tar or petroleum jelly application (HCPCS:96910)
• Biopsy of related skin growth, first growth (HCPCS:11102)
• Destruction of skin growth, 1-14 growths (HCPCS:17110)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Biopsy of related skin growth, each additional growth (HCPCS:11103)
• Application of light by qualified health care professional to destroy precancer skin growth (HCPCS:96573)
• Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) (HCPCS:J7308)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Administration of chemotherapy into growth, 1-7 (HCPCS:96405)
• Punch biopsy, first skin growth (HCPCS:11104)
• Biopsy of ear (HCPCS:69100)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm (HCPCS:17262)
• Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm (HCPCS:12032)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 9/13/2006 and was last updated on 9/11/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: